“Patient Access to ESRD New Innovative Devices Act”
Posted on May 22, 2019
For Immediate Release May 18, 2019
Contact: Nichole Jefferson, President Home Dialyzors United
Home Dialyzors Supports Baxter Legislation “Patient Access to ESRD New Innovative Devices Act”
Dallas, TX. Home Dialyzors United (HDU) HDU Board President Nichole Jefferson is excited to announce, as part of its mission to educate and inform dialyzors, support of legislation H.R.2710 – To amend title XVIII of the Social Security Act to improve access to innovative new medical devices furnished to individuals with end stage renal disease under part B of the Medicare program by establishing a new device add-on payment adjustment under such part.
The legislation has been a cooperative effort between Baxter and other renal organizations, such as NKF and HDU, to address the a lack of innovative new devices for ESRD Medicare beneficiaries, in part because of the lack of reimbursement incentives for novel devices. H.R.2710 proposes to address this issue by asking the Secretary of Health and Human Services to establish a process to provide —
(1) an add-on payment adjustment for a new medical device reviewed by the Food and Drug Administration under section 513(f)(2) or section 515 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360c, 360e) on or after January 1, 2020, and furnished to a beneficiary for the diagnosis, treatment, or management of end stage renal disease.
To learn more about the legislation, how HDU supports patients, and how patients can support HDU visit http://www.homedialyzorsunited.org.